NEWAMSTERDAM PHARMA COMPANY

Ticker: NAMS CUSIP: N62509109 Class: Stock

Ensign Peak Advisors, Inc's Holding History (CIK: 0001454984)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 549,511 Value ($000) $19,277 Avg Close $36.39 Range $28.19 - $42.00
Q3 2024
Shares 245,571 Value ($000) $4,076 Avg Close $17.30 Range $15.19 - $21.48
Q2 2024
Shares 246,106 Value ($000) $4,728 Avg Close $20.06 Range $16.62 - $24.79
Q1 2024
Shares 246,106 Value ($000) $5,820 Avg Close $20.30 Range $11.18 - $26.35
Q4 2023
Shares 191,956 Value ($000) $2,144 Avg Close $9.16 Range $5.63 - $11.89
Q3 2023
Shares 437,733 Value ($000) $4,049 Avg Close $10.83 Range $8.57 - $12.54
Q2 2023
Shares 441,956 Value ($000) $5,255 Avg Close $13.27 Range $11.03 - $17.00
Q1 2023
Shares 355,000 Value ($000) $4,707 Avg Close $12.62 Range $9.50 - $18.70
Q4 2022
Shares 355,000 Value ($000) $3,870 Avg Close $9.95 Range $7.52 - $32.88